Sisram Medical Ltd (HKG:1696)
Hong Kong · Delayed Price · Currency is HKD 2.140
+0.010 (0.47%)
Aug 21, 2026, 3:59 PM HKT
Sisram Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 371.29 | 365.35 | 349.11 | 359.29 | 354.48 | 294.29 | |
Revenue Growth | 7.35% | 4.65% | -2.83% | 1.36% | 20.45% | 81.56% |
Cost of Revenue | 158.28 | 150.2 | 132.43 | 139.77 | 152.25 | 127.43 |
Gross Profit | 213.02 | 215.14 | 216.68 | 219.53 | 202.23 | 166.86 |
Selling, General & Admin | 172.1 | 165.73 | 165.09 | 159.44 | 128.76 | 100.71 |
Research & Development | 15.49 | 16.86 | 15.94 | 18.03 | 18.02 | 15.59 |
Other Operating Expenses | 4.62 | 5.53 | 7.98 | 4.03 | 10.04 | 7.8 |
Operating Expenses | 192.21 | 188.12 | 189 | 181.5 | 156.82 | 124.1 |
Operating Income | 20.81 | 27.03 | 27.68 | 38.03 | 45.41 | 42.76 |
Interest Expense | -3.82 | -3.25 | -2.46 | -2.06 | -1.74 | -2.01 |
Interest & Investment Income | 0.82 | 0.96 | 1.32 | 0.6 | 0.61 | 0.54 |
Earnings From Equity Investments | 0.25 | 0.21 | 0.03 | -0.42 | -0.52 | -0.31 |
Currency Exchange Gain (Loss) | -1.16 | 2.51 | - | - | - | 0.49 |
Other Non Operating Income (Expenses) | 2.12 | 1.08 | 1.82 | 0.99 | 0.48 | 0.19 |
EBT Excluding Unusual Items | 19.02 | 28.55 | 28.39 | 37.13 | 44.24 | 41.67 |
Gain (Loss) on Sale of Investments | - | - | 4.15 | - | - | - |
Pretax Income | 19.02 | 28.55 | 32.54 | 37.13 | 44.24 | 41.67 |
Income Tax Expense | 1.95 | 3.55 | 3.78 | 4.23 | 4.16 | 9.15 |
Earnings From Continuing Operations | 17.07 | 25.01 | 28.77 | 32.9 | 40.08 | 32.52 |
Minority Interest in Earnings | -5.64 | -5.99 | -3.64 | -1.4 | 0.09 | -1.28 |
Net Income | 11.44 | 19.02 | 25.13 | 31.5 | 40.17 | 31.25 |
Net Income to Common | 11.44 | 19.02 | 25.13 | 31.5 | 40.17 | 31.25 |
Net Income Growth | -44.49% | -24.32% | -20.23% | -21.59% | 28.57% | 134.15% |
Shares Outstanding (Basic) | 468 | 468 | 468 | 467 | 466 | 453 |
Shares Outstanding (Diluted) | 468 | 468 | 468 | 468 | 467 | 453 |
Shares Change | - | - | - | 0.34% | 3.07% | 2.42% |
EPS (Basic) | 0.02 | 0.04 | 0.05 | 0.07 | 0.09 | 0.07 |
EPS (Diluted) | 0.02 | 0.04 | 0.05 | 0.07 | 0.09 | 0.07 |
EPS Growth | -44.39% | -24.25% | -20.36% | -21.84% | 24.78% | 128.63% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -5.32 | 6.82 | 30.33 | 35.37 | 17.29 | 29.41 |
Free Cash Flow Per Share | -0.01 | 0.01 | 0.07 | 0.08 | 0.04 | 0.07 |
Dividend Per Share | - | 0.012 | 0.016 | 0.020 | 0.022 | 0.020 |
Dividend Growth | - | -24.76% | -19.80% | -8.84% | 10.20% | 123.02% |
Gross Margin | 57.37% | 58.89% | 62.07% | 61.10% | 57.05% | 56.70% |
Operating Margin | 5.60% | 7.40% | 7.93% | 10.58% | 12.81% | 14.53% |
Profit Margin | 3.08% | 5.21% | 7.20% | 8.77% | 11.33% | 10.62% |
Free Cash Flow Margin | -1.43% | 1.87% | 8.69% | 9.84% | 4.88% | 9.99% |
EBITDA | 34.37 | 38.22 | 38.91 | 47.5 | 53.99 | 51.58 |
EBITDA Margin | 9.26% | 10.46% | 11.14% | 13.22% | 15.23% | 17.53% |
D&A For EBITDA | 13.57 | 11.19 | 11.23 | 9.47 | 8.59 | 8.82 |
EBIT | 20.81 | 27.03 | 27.68 | 38.03 | 45.41 | 42.76 |
EBIT Margin | 5.60% | 7.40% | 7.93% | 10.58% | 12.81% | 14.53% |
Effective Tax Rate | 10.23% | 12.42% | 11.60% | 11.40% | 9.41% | 21.96% |